Company intelligence / Profile preview

Pharmadax Inc.

New Taipei City, New Taipei City, Taiwanpharmadax.com ↗

Ownership: Public · 4191
Employees: ~294
Development stage: Commercial

Overview

Pharmadax develops and manufactures specialty generic drugs with a focus on modified release formulations. The company has manufacturing facilities in China with a combined capacity of 600 million tablets per year.

Therapeutic areas: EndocrinologyPsychiatryUrologyCardiovascularNeurologyInfectious Diseases
Modalities: Oral solid controlled-releaseOral pellet controlled-release
Industry: Biotech

Beyond the preview

Go deeper on Pharmadax Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharmadax Inc..

Explore the full profile